Screener
Maze Therapeutics MAZE Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $202.64M-23.4% | $198.77M-32.5% | $189.25M-3.8% | $316.77M+112% | $264.54M+51.1% | ||
| $208.44M— | $153.62M— | $152.67M— | $67.16M— | —— | ||
| $420.42M+55.1% | $379.78M+26.7% | $349.72M+73.4% | $391.3M— | $271.15M— | ||
| $4.39M-26.9% | $4.68M-25.8% | $5.04M-24.4% | $5.54M— | $6.01M— | ||
| $531.63M+75.2% | $419.71M+26.1% | $397.13M+65.1% | $422.06M— | $303.52M— | ||
| $2.21M-39.7% | $4.01M+66.9% | $1.79M-7.5% | $2.92M+350% | $3.67M+847% | ||
| $0— | $0— | —— | —— | —— | ||
| $22.96M+15.4% | $21.24M+14.1% | $22.56M+9.1% | $22.11M— | $19.9M— | ||
| $38.96M— | $38.83M— | —— | —— | —— | ||
| $78.5M+90.2% | $78.01M+91.3% | $42.16M-3.4% | $42.62M— | $41.28M— | ||
| $56K+27.3% | $50K+13.6% | $49K+2,350% | $48K— | $44K— | ||
| -$558.48M-31.4% | -$513.76M-31.3% | -$489.55M-36.6% | -$454.98M— | -$424.89M— | ||
| $453.12M+72.8% | $341.7M+17.0% | $354.97M+214% | $379.44M— | $262.24M— | ||
| $531.63M+75.2% | $419.71M+26.1% | $397.13M+65.1% | $422.06M— | $303.52M— |
FAQ
- What are Maze Therapeutics's total assets?
- Maze Therapeutics (MAZE) holds $531.6M in total assets, up 75.1% year over year.
- How much debt does Maze Therapeutics have?
- Maze Therapeutics carries $60.4M in total debt against $453.1M of shareholders' equity, a debt-to-equity ratio of 0.13.
- How much cash does Maze Therapeutics have?
- Maze Therapeutics holds $202.6M in cash and equivalents.
- Can Maze Therapeutics cover its short-term obligations?
- Its current ratio is 18.31 — current assets exceed current liabilities.
- Where does Maze Therapeutics's balance sheet data come from?
- Every line is extracted from Maze Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.